Resitu: minimally invasive surgical technology


Guided by ultrasound, the doctor places the tip of the instrument at the site of the lesion. Simply pulling back the handle creates a vacuum that allows the entire lesion to enter the tube. The instrument is pushed gently into the breast to ensure the whole lesion is inside the tube. The diathermic electrode is pushed forward with the slider on the handle. Rotating the handle severs the lesion from the surrounding area. The instrument is withdrawn with the intact lesion inside the tube. The intact lesion is sent to histopathology for analysis.

Published 2022-05-06


Resitu Medical AB
Rapsgatan 7B
Uppsala, Sweden

Resitu Medical AB is a Swedish Medical Device company founded in 2019. The company is developing instruments enabling safe removal of intact tissues by a revolutionary technology. The solution has the potential to create a paradigm shift in the management of breast cancer. The portfolio of instruments will speed up the process of cancer management using a minimally invasive approach and facilitating the way radiologists and surgeons work.

By using this website, you agree to our use of cookies. We use cookies to provide you with a great experience and to help our website run effectively.